pioglitazone has been researched along with Deficiency, Yin in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZH | 2 |
| Xia, CD | 2 |
| Wei, ZX | 2 |
2 trials available for pioglitazone and Deficiency, Yin
| Article | Year |
|---|---|
[Treatment of type 2 diabetes mellitus patients of qi-yin deficiency phlegm-stasis inter-obstruction syndrome by jiangtang xiaozhi capsule and pioglitazone tablet: a non-inferiority randomized controlled trial].
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Pi | 2014 |
[Clinical study of Jiangtang Xiaozhi Capsule in treating type 2 diabetes mellitus patients].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Humans; Male; | 2012 |